Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial

Journal of the American College of Nutrition

Volumn 36, Issue 7, 2017, Pages 497-506

  Jafarnejad, Sadegh ^a   Djafarian, Kurosh ^a   Fazeli, Mohammad Reza ^b   Yekaninejad, Mir Saeed ^c   Rostamian, Abdolrahman ^c   Keshavarz, Seyed Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

bone biomarkers; osteopenia; osteoporosis; postmenopausal women; pro inflammatory cytokines; Probiotic

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; GERILACT; INTERLEUKIN 1BETA; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR; VITAMIN D; AMINO ACID; BIOLOGICAL MARKER; VITAMIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; OSTEOPENIA; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; BLOOD; BONE; BONE REMODELING; CALCIUM INTAKE; DIETARY SUPPLEMENT; DRUG EFFECT; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; THERAPEUTIC USE; TREATMENT OUTCOME;

ALKALINE PHOSPHATASE; AMINO ACIDS; BIOMARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; POSTMENOPAUSE; PROBIOTICS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMINS;

EID: 85021082529     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2017.1318724     Document Type: Article

References (63)

1. Raisz LG, : Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325, 2005.
2. Johnell O, Kanis JA, : An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733, 2006.
3. Irani AD, Poorolajal J, Khalilian A, Esmailnasab N, Cheraghi Z, : Prevalence of osteoporosis in Iran: a meta-analysis. J Res Med Sci 18:759–766, 2013.
4. Pacifici R, : Estrogen deficiency, T cells and bone loss. Cell Immunol 252:68–80, 2008.
5. Chen JS, Sambrook PN, : Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol 8:81–91, 2011.
6. Reid IR, : Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol 11:418–428, 2015.
7. Sambrook PJ, Nordin BE, Goss AN, : Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust 194:51–52; author reply 52, 2011.
8. Adams C, Cannell S, : Women's beliefs about “natural” hormones and natural hormone replacement therapy. Menopause 8:433–440, 2001.
9. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Montagnani A, Monaco R, Gennari C, : Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis. Calcif Tissue Int 65:359–364, 1999.
10. Food and Agriculture Organization/World Health Organization: “Guidelines for the Evaluation of Probiotics in Food: Report of a Joint FAO/WHO Working Group.” Ontario, Canada: Food and Agriculture Organization of the United Nations and World Health Organization, 2002.
11. Food and Agriculture Organization/World Health Organization: “Probiotics in Food. Health and Nutritional Properties and Guidelines for Evaluation.” Rome, Italy: AGN FAO, 2006.
12. Jackson MA, Jeffery IB, Beaumont M, Bell JT, Clark AG, Ley RE, O'Toole PW, Spector TD, Steves CJ, : Signatures of early frailty in the gut microbiota. Genome Med 8:8, 2016.
13. Singh T, Newman AB, : Inflammatory markers in population studies of aging. Ageing Res Rev 10:319–329, 2011.
14. Ali T, Lam D, Bronze MS, Humphrey MB, : Osteoporosis in inflammatory bowel disease. Am J Med 122:599–604, 2009.
15. Ciucci T, Ibanez L, Boucoiran A, Birgy-Barelli E, Pene J, Abou-Ezzi G, Arab N, Rouleau M, Hebuterne X, Yssel H, Blin-Wakkach C, Wakkach A, : Bone marrow Th17 TNFalpha cells induce osteoclast differentiation, and link bone destruction to IBD. Gut 64:1072–1081, 2015.
16. Hemarajata P, Versalovic J, : Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 6:39–51, 2013.
17. Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, Parameswaran N, McCabe LR, : Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 229:1822–1830, 2014.
18. Ghanem KZ, Badawy IH, Abdel-Salam AM, : Influence of yoghurt and probiotic yoghurt on the absorption of calcium, magnesium, iron and bone mineralization in rats. Milchwissenschaft 59:472–475, 2004.
19. Mutus R, Kocabagli N, Alp M, Acar N, Eren M, Gezen SS, : The effect of dietary probiotic supplementation on tibial bone characteristics and strength in broilers. Poult Sci 85:1621–1625, 2006.
20. Lavasani S, Dzhambazov B, Nouri M, Fak F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Westrom B, : A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 5(2):e9009, 2010.
21. Li JY, et al.: Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126:2049–2063, 2016.
22. Pytlik M, Folwarczna J, Janiec W, : Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia. Calcif Tissue Int 75:225–230, 2004.
23. Williams S, Wakisaka A, Zeng QQ, Barnes J, Martin G, Wechter WJ, Liang CT, : Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone 19:637–644, 1996.
24. Moher D, Schulz KF, Altman DG, : The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 1:2, 2001.
25. Vanlint SJ, Ried K, : Efficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCT. Maturitas 71:44–48, 2012.
26. World Health Organization: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129, 1994.
27. Kelishadi R, Ardalan G, Gheiratmand R, Gouya MM, Razaghi EM, Delavari A, Majdzadeh R, Heshmat R, Motaghian M, Barekati H, Mahmoud-Arabi MS, Riazi MM, : Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ 85:19–26, 2007.
28. Kim JG, Lee E, Kim SH, Whang KY, Oh S, Imm J-Y, : Effects of a Lactobacillus casei 393 fermented milk product on bone metabolism in ovariectomised rats. Int Dairy J 19:690–695, 2009.
29. Parvaneh K, Ebrahimi M, Sabran MR, Karimi G, Hwei AN, Abdul-Majeed S, Ahmad Z, Ibrahim Z, Jamaluddin R, : Probiotics (Bifidobacterium longum) increase bone mass density and upregulate Sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy. Biomed Res Int 2015:897639, 2015.
30. Scholz-Ahrens KE, Adolphi B, Rochat F, Barclay DV, de Vrese M, Açil Y, Schrezenmeir J, : Effects of probiotics, prebiotics, and synbiotics on mineral metabolism in ovariectomized rats—impact of bacterial mass, intestinal absorptive area and reduction of bone turn-over. NFS J 3:41–50, 2016.
31. Chiang SS, Pan TM, : Antiosteoporotic effects of Lactobacillus-fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J Agric Food Chem 59:7734–7742, 2011.
32. McCabe LR, Irwin R, Schaefer L, Britton RA, : Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol 228:1793–1798, 2013.
33. Azinge EC, Bolarin DM, : Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies. Niger J Physiol Sci 21:21–25, 2006.
34. Hooshmand S, Chai SC, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH, : Comparative effects of dried plum and dried apple on bone in postmenopausal women. Br J Nutr 106:923–930, 2011.
35. Lenora J, Norrgren K, Thorsson O, Wollmer P, Obrant KJ, Ivaska KK, : Bone turnover markers are correlated with total skeletal uptake of 99mTc-methylene diphosphonate (99mTc-MDP). BMC Med Phys 9:3, 2009.
36. Wang J, Pei F, Tu C, Zhang H, Qiu X, : Serum bone turnover markers in patients with primary bone tumors. Oncology 72:338–342, 2007.
37. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Acil Y, Gluer CC, Schrezenmeir J, : Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137(Suppl 2):838s–846s, 2007.
38. Adolphi B, Scholz-Ahrens KE, de Vrese M, Acil Y, Laue C, Schrezenmeir J, : Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and casein phosphopeptides on bone metabolism in healthy, postmenopausal women. Eur J Nutr 48:45–53, 2009.
39. Szulc P, Delmas PD, : Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 19:1683–1704, 2008.
40. Ivaska KK, Hentunen TA, Vaaraniemi J, Ylipahkala H, Pettersson K, Vaananen HK, : Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361–18369, 2004.
41. Foureaux RC, Messora MR, de Oliveira LF, Napimoga MH, Pereira AN, Ferreira MS, Pereira LJ, : Effects of probiotic therapy on metabolic and inflammatory parameters of rats with ligature-induced periodontitis associated with restraint stress. J Periodontol 85:975–983, 2014.
42. Ohlsson C, Engdahl C, Fak F, Andersson A, Windahl SH, Farman HH, Moverare-Skrtic S, Islander U, Sjogren K, : Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One 9:e92368, 2014.
43. Karkkainen MU, Lamberg-Allardt CJ, Ahonen S, Valimaki M, : Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism. Am J Clin Nutr 74:335–342, 2001.
44. Narva M, Collin M, Lamberg-Allardt C, Karkkainen M, Poussa T, Vapaatalo H, Korpela R, : Effects of long-term intervention with Lactobacillus helveticus–fermented milk on bone mineral density and bone mineral content in growing rats. Ann Nutr Metab 48:228–234, 2004.
45. Campbell JM, Fahey GC, Jr, Wolf BW, : Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127:130–136, 1997.
46. Weber P, : The role of vitamins in the prevention of osteoporosis—a brief status report. Int J Vitam Nutr Res 69:194–197, 1999.
47. Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T, : Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J Oral Microbiol 2, 2010. doi:10.3402/jom.v20.5532
48. Lorenzo J, Horowitz M, Choi Y, : Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403–440, 2008.
49. Collins FL, et al.: Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. PLoS One 11:e0153180, 2016.
50. Hooshmand S, Brisco JR, Arjmandi BH, : The effect of dried plum on serum levels of receptor activator of NF-kappaB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. Br J Nutr 112:55–60, 2014.
51. Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP, : Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol 64:354–357, 2011.
52. Kostenuik PJ, : Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618–625, 2005.
53. Findlay D, Chehade M, Tsangari H, Neale S, Hay S, Hopwood B, Pannach S, O'Loughlin P, Fazzalari N, : Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. Arthritis Res Ther 10(1):R2, 2008.
54. Findlay DM, Atkins GJ, : Relationship between serum RANKL and RANKL in bone. Osteoporos Int 22:2597–2602, 2011.
55. Bron PA, van Baarlen P, Kleerebezem M, : Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10:66–78, 2011.
56. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH, : Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107:2159–2164, 2010.
57. Maekawa T, Hajishengallis G, : Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodontal Res 49:785–791, 2014.
58. Harris L, Senagore P, Young VB, McCabe LR, : Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol 296:G1020–G1029, 2009.
59. Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR, : Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis 19:1586–1597, 2013.
60. Xu S, Wang Y, Lu J, Xu J, : Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int 32:3397–403, 2012.
61. Garcia VG, Knoll LR, Longo M, Novaes VC, Assem NZ, Ervolino E, de Toledo BE, Theodoro LH, : Effect of the probiotic Saccharomyces cerevisiae on ligature-induced periodontitis in rats. J Periodontal Res 51:26–37, 2016.
62. Wang IK, Wu YY, Yang YF, Ting IW, Lin CC, Yen TH, Chen JH, Wang CH, Huang CC, Lin HC, : The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes 6:423–430, 2015.
63. Dong H, Rowland I, Yaqoob P, : Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108:459–470, 2012.